A Binding Kinetics Study of Human Adenosine A(3) Receptor Agonists

The human adenosine A(3) (hA(3)) receptor has been suggested as a viable drug target in inflammatory diseases and in cancer. So far, a number of selective hA(3) receptor agonists (e.g. IB-MECA and 2-Cl-IB-MECA) inducing anti-inflammatory or anticancer effects are under clinical investigation. Drug-t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Biochem Pharmacol
Asıl Yazarlar: Xia, Lizi, Kyrizaki, Athina, Tosh, Dilip K., van Duijl, Tirsa T., Roorda, Jacomina Cornelia, Jacobson, Kenneth A., IJzerman, Adriaan P., Heitman, Laura H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2018
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5959751/
https://ncbi.nlm.nih.gov/pubmed/29305857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2017.12.026
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller